![Cdc7-IN-3 Catalog No.:M23945-C ]tridec-3-en-9-yl]-2-methylpenta-2](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M23945_1635921864.gif?v=1635921865)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
]tridec-3-en-9-yl]-2-methylpenta-2
PubMed PMID: 27283322
Chemical Name: N-(2-(2-(2-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)- amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)- piperidin-1-yl)ethoxy)ethoxy)ethyl)-2-((2-(2
Thonningianin A
86 μg/mL for human breast cancer cells (MCF-7 and MDA-MB-231)
Cdc7-IN-3 Catalog No.:M23945-C ]tridec-3-en-9-yl]-2-methylpenta-2Cdc7 IN 3 (compound I A) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I B. Cdc7 is a serine threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle. Product information CAS Number: 1402057 87 7 Molecular Weight: 398. 41 Formula: C20H22N4O5 Chemical Name: propan 2 yl 4 hydroxy 2 [(morpholin 4 yl)amino] 5 ({3H pyrrolo[2,3 b]pyridin 3 ylidene}methyl)furan 3 carboxylate
US$ 12.00
US$ 172.00
US$ 195.00
US$ 125.00
US$ 180.00
US$ 156.00
US$ 12.00
US$ 12.00
US$ 15.00
US$ 156.00
US$ 179.00
US$ 180.00
US$ 175.00
US$ 50.00